Viewing nowCombinationTelmisartan/Amlodipine/Lipitor 80/5/10 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 201904521 · Approved 2019.07.03 · Insurance code 649807470
Treatment of hypertension and dyslipidemia; suppression of atherosclerosis progression and cardiovascular disease risk
This medication is used in patients who need concomitant therapy with telmisartan and amlodipine and rosuvastatin. The telmisartan/amlodipine combination is effective for patients with essential hypertension when blood pressure is not adequately controlled with monotherapy. Additionally, rosuvastatin is used for hypercholesterolemia and dyslipidemia that are not controlled by diet and exercise alone. By treating hypercholesterolemia, it helps slow the progression of atherosclerosis and reduces the risk of cardiovascular diseases. It is particularly useful in patients with elevated high-sensitivity C-reactive protein levels and cardiovascular risk factors to lower the risk of stroke, myocardial infarction, and vascular interventions. Therefore, this medication is used to manage both hypertension and hyperlipidemia simultaneously to prevent cardiovascular diseases.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. Patients taking telmisartan/amlodipine combination tablets together with rosuvastatin as a single-ingredient product may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin, and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg per day. 2. Older adults: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Ethnicity: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.
This medication should not be used during pregnancy. If pregnancy is confirmed, use should be discontinued immediately, and women who may become pregnant should use appropriate contraceptive methods. Patients with hypersensitivity to any components in this medication or those with certain genetic disorders should not take it. Moreover, patients with severe liver disease or renal failure and those with specific heart conditions should be cautious when taking this medication due to potential risks. Elderly patients or those with hypotension, hyperkalemia, or impaired liver function should exercise increased caution when taking this medication, and it is advisable to periodically monitor liver and kidney function. This medication may cause myalgia, myopathy, and in rare cases, severe muscle damage known as rhabdomyolysis, so patients should consult their physician immediately if symptoms such as myalgia or muscle weakness occur. Regular blood tests to check levels of creatine kinase (CK), a marker of muscle damage, are recommended, and if levels rise significantly, medication should be discontinued. Liver enzyme levels may also become abnormal, thus it is important to periodically test enzyme levels, and if they deviate significantly from the normal range, use should be stopped. This drug may interact with other antihypertensive or lipid-lowering medications, so it is imperative to inform the physician or pharmacist if other medications are being taken. It is advisable for breastfeeding women not to take this medication; if unavoidable, breastfeeding should be discontinued. In the case of overdose, symptoms such as hypotension, dizziness, and renal dysfunction may occur, and immediate medical attention should be sought in such instances. Patients should be cautious about dizziness or drowsiness occurring while driving or operating machinery during the use of this drug. It is not recommended for children as safety and efficacy have not been established in this population. Finally, this medication should be stored out of reach of children, and it is safer to avoid transferring it to other containers.
Peripheral edema, dyspepsia, frequent bowel movements, diabetes mellitus, dizziness, dry vesicular sounds, urticaria, unstable angina, onychomycosis, lumbar spinal canal stenosis, otorrhea, vertigo, chronic gastritis, hiatal hernia, musculoskeletal pain, neck pain, nasopharyngitis, upper abdominal discomfort, upper abdominal pain, position-related dizziness, dysuria, rhinitis, oropharyngeal discomfort, pulmonary disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory tract infection, back pain, sinusitis, diarrhea, pharyngitis, influenza-like syndrome, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, sensory abnormalities, involuntary muscle contractions, sensory impairment, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, anxiety, depression, nervousness, infection, fungal infection, abscess, otitis media, asthma, bronchitis, rhinitis, dyspnea, epistaxis, dermatitis, rash, eczema, pruritus, frequent urination, cystitis, cerebrovascular disease, visual disturbances, conjunctivitis, ear pain, vascular edema, fever, leg pain, lethargy, thrombocytopenia, increased uric acid, liver function abnormalities, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, rhabdomyolysis, decreased intravascular blood volume, hypotension, tachycardia, bradycardia, muscle cramps, bradycardia, eosinophilia, thrombocytopenia, increased uric acid, liver function abnormalities and liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, rhabdomyolysis, headache, edema, flushing, palpitations, fatigue, nausea, abdominal pain, drowsiness, arrhythmia, ventricular tachycardia, atrial fibrillation, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, tremors, anorexia, dysphagia, pancreatitis, gingival hyperplasia, myasthenia, back pain, burning sensation, lethargy, pain, stiffness, weight gain, weight loss, arthralgia, osteoarthritis, muscle cramps, sexual dysfunction, insomnia, nervousness, abnormal dreams, depersonalization, dyspnea, epistaxis, vascular edema, erythema multiforme, rash, erythematous rash, papular rash, frequent urination, urinary dysfunction, nocturia, dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in containers that block light. Additionally, the medication should be stored at room temperature, i.e., between 1 to 30 degrees Celsius. This way, the effects of the medication are well maintained and can be used safely.
Oval bicolored tablet that consists of a white layer and a light blue layer
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myeong Mun Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.